Table 1. Adolescent acute lymphoblastic... | American Society of Hematology

Table 1.

Adolescent acute lymphoblastic leukemia (ALL) outcome according to treatment protocol.²

Site	Age Range, yr	Number	5-year EFS	Ref.
*7-year EFS
Abbreviations: CCG, Children’s Cancer Group; CALGB, Cancer and Leukemia Group B; FRALLE, French Acute Lymphoblastic Leukemia Pediatric group; LALA, Leucémie Aiguë Lymphoblastique de l’Adulte; DCOG, Dutch Childhood Oncology Group; HOVON, Dutch-Belgian Hemato-Oncology Cooperative Group; UKALLXII-United Kingdom Acute Lymphoblastic Leukemia; NOPHO 92, Nordic Society of Pediatric Haematology and Oncology
USA				34
CCG	16–21	197	63*
CALGB	16–21	124	34*
France				35
FRALLE 93	15–20	77	67
LALA 94	15–20	100	41
The Netherlands				36
DCOG	15–18	47	69
HOVON	15–18	44	34
United Kingdom				37
MRC ALL	15–17	61	65
UKALLXII	15–17	67	49
Sweden				38
NOPHO 92	15–18	36	74
Adult	15–20	21	39

Site	Age Range, yr	Number	5-year EFS	Ref.
*7-year EFS
Abbreviations: CCG, Children’s Cancer Group; CALGB, Cancer and Leukemia Group B; FRALLE, French Acute Lymphoblastic Leukemia Pediatric group; LALA, Leucémie Aiguë Lymphoblastique de l’Adulte; DCOG, Dutch Childhood Oncology Group; HOVON, Dutch-Belgian Hemato-Oncology Cooperative Group; UKALLXII-United Kingdom Acute Lymphoblastic Leukemia; NOPHO 92, Nordic Society of Pediatric Haematology and Oncology
USA				34
CCG	16–21	197	63*
CALGB	16–21	124	34*
France				35
FRALLE 93	15–20	77	67
LALA 94	15–20	100	41
The Netherlands				36
DCOG	15–18	47	69
HOVON	15–18	44	34
United Kingdom				37
MRC ALL	15–17	61	65
UKALLXII	15–17	67	49
Sweden				38
NOPHO 92	15–18	36	74
Adult	15–20	21	39